LON:AOR - AorTech International Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 123.50
▼ -3 (-2.37%)
1 month | 3 months | 12 months
Get New AorTech International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AOR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AOR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for AorTech International in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 123.50.
N/A
The current consensus among 0 investment analysts is to n/a stock in AorTech International. This rating has held steady since May 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/21/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/18/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/15/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/13/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/13/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
5/27/2020Shore CapitalReiterated RatingHouse Stock
i
11/29/2019Shore CapitalReiterated RatingHouse Stock
i
6/13/2018Stockdale SecuritiesInitiated CoverageBuyGBX 400
i
8/30/2016FinnCapReiterated RatingCorporate
i
(Data available from 4/14/2016 forward)
AorTech International logo
AorTech International plc, together with its subsidiaries, focuses on the commercialization of its biomedical polymer technology, components, and medical devices in the United Kingdom. The company offers Elast-Eon, a bio stable polyurethane material used in long term implantation; and Elast-Eon Carbonate Silicone, a family of biomedical polymers for applications in cardiac pacing leads, orthopedics, and spinal discs, as well as in other applications where the device requires a high level of mechanical performance. It also provides Elast-Eon Reaction Injection Molding products for use in high-precision medical device components. In addition, the company licenses its technology; and offers support services to other medical device companies. AorTech International plc was incorporated in 1996 and is headquartered in Weybridge, the United Kingdom.
Read More

Today's Range

Now: GBX 123.50
122
126

50 Day Range

MA: GBX 123.50
123.50
123.50

52 Week Range

Now: GBX 123.50
40.50
134.70

Volume

7,419 shs

Average Volume

40,686 shs

Market Capitalization

£19.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of AorTech International?

The following Wall Street sell-side analysts have issued reports on AorTech International in the last twelve months: Shore Capital.
View the latest analyst ratings for AOR.

What is the current price target for AorTech International?

0 Wall Street analysts have set twelve-month price targets for AorTech International in the last year. has the lowest price target set, forecasting a price of £100,000 for AorTech International in the next year.
View the latest price targets for AOR.

What is the current consensus analyst rating for AorTech International?

AorTech International currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AOR.

What other companies compete with AorTech International?

How do I contact AorTech International's investor relations team?

AorTech International's physical mailing address is Level Two Springfield HSE, 23 Oatlands Drive, WEYBRIDGE, KT13 9LZ, United Kingdom. The company's listed phone number is +44-1932-252123. The official website for AorTech International is www.aortech.net.